Publication | Closed Access

Biological evaluation of 2-pyrazolinyl-1-carbothioamide derivatives against HCT116 human colorectal cancer cell lines and elucidation on QSAR and molecular binding modes

Medicinal ChemistryChemoprevention StrategyMedicinePharmacotherapy2-Pyrazolinyl-1-carbothioamide DerivativesMolecular Binding ModesBiological EvaluationDrug DevelopmentAnti-cancer AgentPharmacologyRadiation OncologyDrug Discovery